Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

686
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
686
Neural Regulation01:37

Neural Regulation

39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

982
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
982
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

656
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
656
Cross-bridge Cycle01:26

Cross-bridge Cycle

118.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurodegeneration and Demyelination in the Multiple Sclerosis Spinal Cord: Clinical, Pathological, and 7T MRI Perspectives.

Neurology·2025
Same author

High-resolution diffusion tensor imaging of the fornix predicts memory function in multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2024
Same author

Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2023
Same author

Correction to: Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis.

Acta neuropathologica communications·2022
Same author

Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis.

Acta neuropathologica communications·2022
Same author

Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease.

Journal of immunology (Baltimore, Md. : 1950)·2022
Same journal

Friend or Foe? The Dual Role of Ferroptosis in Tumor Immunity and Immunotherapy.

WIREs mechanisms of disease·2026
Same journal

Nager Syndrome Revisited: Integrating In Vivo and In Vitro Models to Decipher SF3B4-Dependent Tissue Coordination.

WIREs mechanisms of disease·2026
Same journal

Anna Karenina Principle, Immune-Oncology-Microbiome Trio and Cancer Microbiome Therapy.

WIREs mechanisms of disease·2025
Same journal

SARS-CoV-2: A Liver Brief.

WIREs mechanisms of disease·2025
Same journal

The Nucleolus and Its Associated Pathologies.

WIREs mechanisms of disease·2025
Same journal

Biomedical Models: Use of Zebrafish as a Multi-Utility In Vivo Tool Box.

WIREs mechanisms of disease·2025
See all related articles

Related Experiment Video

Updated: Sep 2, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Neurodegeneration in multiple sclerosis.

Gabrielle M Mey1, Kedar R Mahajan1,2, Tara M DeSilva1

  • 1Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, and Case Western Reserve University, Cleveland, Ohio, USA.

Wires Mechanisms of Disease
|August 10, 2022
PubMed
Summary
This summary is machine-generated.

Axonal loss in multiple sclerosis (MS) drives permanent disability. New research explores neuroprotective strategies to combat neurodegeneration and promote repair in the central nervous system (CNS).

Keywords:
axonal injurydemyelinating diseasesmultiple sclerosisneurodegenerationneuroinflammation

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.8K
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.1K

Related Experiment Videos

Last Updated: Sep 2, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.8K
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.1K

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a complex CNS disease causing axonal loss and neurodegeneration.
  • Current immunomodulatory therapies manage inflammatory relapses but do not halt progressive disease or cure MS.
  • Axonal degeneration contributes significantly to irreversible neurological deficits in MS patients.

Purpose of the Study:

  • To review current understanding of MS pathogenesis, focusing on mechanisms of neurodegeneration.
  • To identify early signs of axonal dysfunction and factors contributing to chronic axonal loss.
  • To highlight the need for neuroprotective and regenerative strategies for MS treatment.

Main Methods:

  • Analysis of data from MS patients, post-mortem studies, and animal models of demyelination.
  • Review of proposed MRI and molecular biomarkers for predicting neurodegeneration.
  • Examination of early axonal dysfunction indicators like impaired mitochondrial trafficking and synaptic alterations.

Main Results:

  • Chronic demyelination and inflammation in the CNS perpetuate axonal loss.
  • Impaired remyelination hinders repair processes.
  • Early axonal dysfunction includes mitochondrial, structural, and synaptic changes.

Conclusions:

  • Understanding MS pathogenesis is crucial for developing neuroprotective therapies.
  • Regenerative and neuroprotective strategies are essential for preserving axonal integrity.
  • Early intervention is critical to rescue axonal function and mitigate CNS atrophy in MS.